Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant

NCT00790439 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Stopped Due to funding limitations

Conditions

Diabetes Mellitus, Type I

Interventions

DRUG: Low Molecular Weight Sulfated Dextran
DRUG: Heparin
DRUG: Mycophenolate Mofetil
DRUG: Sirolimus
DRUG: Tacrolimus
DRUG: Cyclosporine
DRUG: Daclizumab
DRUG: Basiliximab
BIOLOGICAL: Allogeneic Pancreatic Islet Cells

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]